BIOMAT Database Logo BIOMAT Database Logo

Serum lipid and lipoprotein levels in Japanese patients with familial hypercholesterolemia. 1979

H Mabuchi, and R Tatami, and K Ueda, and R Ueda, and T Haba, and T Kametani, and A Watanabe, and T Wakasugi, and S Ito, and J Koizumi, and M Ohta, and S Miyamoto, and R Takeda

UI MeSH Term Description Entries
D006949 Hyperlipidemias Conditions with excess LIPIDS in the blood. Hyperlipemia,Hyperlipidemia,Lipemia,Lipidemia,Hyperlipemias,Lipemias,Lipidemias
D007564 Japan A country in eastern Asia, island chain between the North Pacific Ocean and the Sea of Japan, east of the Korean Peninsula. The capital is Tokyo. Bonin Islands
D008055 Lipids A generic term for fats and lipoids, the alcohol-ether-soluble constituents of protoplasm, which are insoluble in water. They comprise the fats, fatty oils, essential oils, waxes, phospholipids, glycolipids, sulfolipids, aminolipids, chromolipids (lipochromes), and fatty acids. (Grant & Hackh's Chemical Dictionary, 5th ed) Lipid
D008074 Lipoproteins Lipid-protein complexes involved in the transportation and metabolism of lipids in the body. They are spherical particles consisting of a hydrophobic core of TRIGLYCERIDES and CHOLESTEROL ESTERS surrounded by a layer of hydrophilic free CHOLESTEROL; PHOSPHOLIPIDS; and APOLIPOPROTEINS. Lipoproteins are classified by their varying buoyant density and sizes. Circulating Lipoproteins,Lipoprotein,Lipoproteins, Circulating
D008077 Lipoproteins, LDL A class of lipoproteins of small size (18-25 nm) and light (1.019-1.063 g/ml) particles with a core composed mainly of CHOLESTEROL ESTERS and smaller amounts of TRIGLYCERIDES. The surface monolayer consists mostly of PHOSPHOLIPIDS, a single copy of APOLIPOPROTEIN B-100, and free cholesterol molecules. The main LDL function is to transport cholesterol and cholesterol esters to extrahepatic tissues. Low-Density Lipoprotein,Low-Density Lipoproteins,beta-Lipoprotein,beta-Lipoproteins,LDL(1),LDL(2),LDL-1,LDL-2,LDL1,LDL2,Low-Density Lipoprotein 1,Low-Density Lipoprotein 2,LDL Lipoproteins,Lipoprotein, Low-Density,Lipoproteins, Low-Density,Low Density Lipoprotein,Low Density Lipoprotein 1,Low Density Lipoprotein 2,Low Density Lipoproteins,beta Lipoprotein,beta Lipoproteins
D008079 Lipoproteins, VLDL A class of lipoproteins of very light (0.93-1.006 g/ml) large size (30-80 nm) particles with a core composed mainly of TRIGLYCERIDES and a surface monolayer of PHOSPHOLIPIDS and CHOLESTEROL into which are imbedded the apolipoproteins B, E, and C. VLDL facilitates the transport of endogenously made triglycerides to extrahepatic tissues. As triglycerides and Apo C are removed, VLDL is converted to INTERMEDIATE-DENSITY LIPOPROTEINS, then to LOW-DENSITY LIPOPROTEINS from which cholesterol is delivered to the extrahepatic tissues. Pre-beta-Lipoprotein,Prebeta-Lipoprotein,Prebeta-Lipoproteins,Very Low Density Lipoprotein,Very-Low-Density Lipoprotein,Very-Low-Density Lipoproteins,Lipoprotein VLDL II,Lipoproteins, VLDL I,Lipoproteins, VLDL III,Lipoproteins, VLDL1,Lipoproteins, VLDL2,Lipoproteins, VLDL3,Pre-beta-Lipoproteins,Lipoprotein, Very-Low-Density,Lipoproteins, Very-Low-Density,Pre beta Lipoprotein,Pre beta Lipoproteins,Prebeta Lipoprotein,Prebeta Lipoproteins,VLDL Lipoproteins,VLDL1 Lipoproteins,VLDL2 Lipoproteins,VLDL3 Lipoproteins,Very Low Density Lipoproteins
D010743 Phospholipids Lipids containing one or more phosphate groups, particularly those derived from either glycerol (phosphoglycerides see GLYCEROPHOSPHOLIPIDS) or sphingosine (SPHINGOLIPIDS). They are polar lipids that are of great importance for the structure and function of cell membranes and are the most abundant of membrane lipids, although not stored in large amounts in the system. Phosphatides,Phospholipid
D002784 Cholesterol The principal sterol of all higher animals, distributed in body tissues, especially the brain and spinal cord, and in animal fats and oils. Epicholesterol
D006579 Heterozygote An individual having different alleles at one or more loci regarding a specific character. Carriers, Genetic,Genetic Carriers,Carrier, Genetic,Genetic Carrier,Heterozygotes
D006720 Homozygote An individual in which both alleles at a given locus are identical. Homozygotes

Related Publications

H Mabuchi, and R Tatami, and K Ueda, and R Ueda, and T Haba, and T Kametani, and A Watanabe, and T Wakasugi, and S Ito, and J Koizumi, and M Ohta, and S Miyamoto, and R Takeda
Serum and lipoprotein lipid levels in diabetic patients with familial hypercholesterolemia.
December 1983, The Tohoku journal of experimental medicine,
H Mabuchi, and R Tatami, and K Ueda, and R Ueda, and T Haba, and T Kametani, and A Watanabe, and T Wakasugi, and S Ito, and J Koizumi, and M Ohta, and S Miyamoto, and R Takeda
Effects of CS-514 on serum lipoprotein lipid and apolipoprotein levels in patients with familial hypercholesterolemia.
May 1987, Metabolism: clinical and experimental,
H Mabuchi, and R Tatami, and K Ueda, and R Ueda, and T Haba, and T Kametani, and A Watanabe, and T Wakasugi, and S Ito, and J Koizumi, and M Ohta, and S Miyamoto, and R Takeda
Relation of Serum Lipoprotein(a) Levels to Lipoprotein and Apolipoprotein Profiles and Atherosclerotic Diseases in Japanese Patients with Heterozygous Familial Hypercholesterolemia: Familial Hypercholesterolemia Expert Forum (FAME) Study.
August 2022, Journal of atherosclerosis and thrombosis,
H Mabuchi, and R Tatami, and K Ueda, and R Ueda, and T Haba, and T Kametani, and A Watanabe, and T Wakasugi, and S Ito, and J Koizumi, and M Ohta, and S Miyamoto, and R Takeda
Serum lipid and apolipoprotein A and B levels in familial hypercholesterolemia.
June 1983, Australian and New Zealand journal of medicine,
H Mabuchi, and R Tatami, and K Ueda, and R Ueda, and T Haba, and T Kametani, and A Watanabe, and T Wakasugi, and S Ito, and J Koizumi, and M Ohta, and S Miyamoto, and R Takeda
[Serum lipoprotein (a) levels during treatment with LDL apheresis for homozygous familial hypercholesterolemia].
October 1992, Medicina clinica,
H Mabuchi, and R Tatami, and K Ueda, and R Ueda, and T Haba, and T Kametani, and A Watanabe, and T Wakasugi, and S Ito, and J Koizumi, and M Ohta, and S Miyamoto, and R Takeda
Epipolymorphisms within lipoprotein genes contribute independently to plasma lipid levels in familial hypercholesterolemia.
May 2014, Epigenetics,
H Mabuchi, and R Tatami, and K Ueda, and R Ueda, and T Haba, and T Kametani, and A Watanabe, and T Wakasugi, and S Ito, and J Koizumi, and M Ohta, and S Miyamoto, and R Takeda
Mutations in the low density lipoprotein receptor gene in Japanese patients with familial hypercholesterolemia.
January 1990, Annals of the New York Academy of Sciences,
H Mabuchi, and R Tatami, and K Ueda, and R Ueda, and T Haba, and T Kametani, and A Watanabe, and T Wakasugi, and S Ito, and J Koizumi, and M Ohta, and S Miyamoto, and R Takeda
Effectiveness and Safety of Lipid-Lowering Drug Treatments in Japanese Patients with Familial Hypercholesterolemia: Familial Hypercholesterolemia Expert Forum (FAME) Study.
May 2022, Journal of atherosclerosis and thrombosis,
H Mabuchi, and R Tatami, and K Ueda, and R Ueda, and T Haba, and T Kametani, and A Watanabe, and T Wakasugi, and S Ito, and J Koizumi, and M Ohta, and S Miyamoto, and R Takeda
Elevated levels of lipoprotein (a) in children with familial hypercholesterolemia.
January 1994, Wiener klinische Wochenschrift,
H Mabuchi, and R Tatami, and K Ueda, and R Ueda, and T Haba, and T Kametani, and A Watanabe, and T Wakasugi, and S Ito, and J Koizumi, and M Ohta, and S Miyamoto, and R Takeda
Lipoprotein(a) levels in coronary heart disease-susceptible and -resistant patients with familial hypercholesterolemia.
June 2011, Atherosclerosis,
Copied contents to your clipboard!